Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bernard, Dorhout"'
Autor:
Bernard Dorhout, Javed Butler, Savina Nodari, Piergiuseppe Agostoni, Jeroen J. Bax, Adriaan A. Voors, Raymond J. Kim, Michele Senni, Mihai Gheorghiade, Wilfried Dinh, Hans-Dirk Düngen, Piotr Ponikowski
Publikováno v:
The Journal of Clinical Pharmacology. 57:440-451
We studied safety and tolerability of neladenoson bialanate, a novel oral selective partial adenosine A1 receptor agonist that maintains the cardioprotective effects of adenosine without the undesired side effects of a full agonist, in 2 pilot studie
Autor:
Chris P H, Lexis, Iwan C C, van der Horst, Erik, Lipsic, Wouter G, Wieringa, Rudolf A, de Boer, Ad F M, van den Heuvel, Hindrik W, van der Werf, Remco A J, Schurer, Gabija, Pundziute, Eng S, Tan, Wybe, Nieuwland, Hendrik M, Willemsen, Bernard, Dorhout, Barbara H W, Molmans, Anouk N A, van der Horst-Schrivers, Bruce H R, Wolffenbuttel, Gert J, ter Horst, Albert C, van Rossum, Jan G P, Tijssen, Hans L, Hillege, Bart J G L, de Smet, Pim, van der Harst, Dirk J, van Veldhuisen, Fred, van den Berg
Publikováno v:
JAMA, 311(15), 1526-1535. American Medical Association
Lexis, C P H, van der Horst, I C C, Lipsic, E, Wieringa, W G, de Boer, R A, van den Heuvel, A F M, van der Werf, H W, Schurer, R A J, Pundziute, G, Tan, E S, Nieuwland, W, Willemsen, H M, Dorhout, B, Molmans, B H W, van der Horst-Schrivers, A, Wolffenbuttel, B H R, ter Horst, G J, van Rossum, A C, Tijssen, J G P, Hillege, H L, De Smet, B J G L, van der Harst, P & van Veldhuisen, D J 2014, ' Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial ', JAMA, vol. 311, no. 15, pp. 1526-1535 . https://doi.org/10.1001/jama.2014.3315
JAMA-Journal of the American Medical Association, 311(15), 1526-1535. AMER MEDICAL ASSOC
Lexis, C P H, van der Horst, I C C, Lipsic, E, Wieringa, W G, de Boer, R A, van den Heuvel, A F M, van der Werf, H W, Schurer, R A J, Pundziute, G, Tan, E S, Nieuwland, W, Willemsen, H M, Dorhout, B, Molmans, B H W, van der Horst-Schrivers, A, Wolffenbuttel, B H R, ter Horst, G J, van Rossum, A C, Tijssen, J G P, Hillege, H L, De Smet, B J G L, van der Harst, P & van Veldhuisen, D J 2014, ' Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial ', JAMA, vol. 311, no. 15, pp. 1526-1535 . https://doi.org/10.1001/jama.2014.3315
JAMA-Journal of the American Medical Association, 311(15), 1526-1535. AMER MEDICAL ASSOC
Importance Metformin treatment is associated with improved outcome after myocardial infarction in patients with diabetes. In animal experimental studies metformin preserves left ventricular function. Objective To evaluate the effect of metformin trea
Autor:
Yoran M. Hummel, Bernard Dorhout, Jan Walter Benjamins, Jan Peter Busman, Frans Riepma, Joost P. van Melle
Publikováno v:
CinC
In multicenter clinical trials images are interpreted and analyzed by an imaging core laboratory (ICL) to generate consistent results with the least possible variance. Currently, transfer of the images can be achieved via postal services (physical me
Publikováno v:
Expert opinion on investigational drugs, 25(1), 117-127. Taylor & Francis Ltd
Introduction: Current available inotropic agents increase cardiac contractility, but are associated with myocardial ischemia, arrhythmias, and mortality. A novel selective cardiac myosin activator, omecamtiv mecarbil (CK-1827452/ AMG-423) is a small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba68fe82977e7edabdf1dabfbf4e83df
https://research.rug.nl/en/publications/cf1dc79a-36b4-49df-983a-59ec00644459
https://research.rug.nl/en/publications/cf1dc79a-36b4-49df-983a-59ec00644459
Publikováno v:
Expert opinion on investigational drugs, 22(8), 1041-1047. Taylor & Francis Ltd
Introduction: Heart failure remains a syndrome with a very high mortality rate and a poor quality of life. For patients with heart failure and a preserved ejection fraction (HFpEF), no drugs have shown to improve mortality and morbidity, and therefor